keyword
https://read.qxmd.com/read/38626072/could-the-mitotic-count-improve-personalized-prognosis-in-melanoma-patients
#21
JOURNAL ARTICLE
Alessandra Buja, Massimo Rugge, Claudia Cozzolino, Francesca Dossi, Manuel Zorzi, Antonella Vecchiato, Giuseppe de Luca, Paolo Del Fiore, Saveria Tropea, Luigi dall'Olmo, Carlo Riccardo Rossi, Giovanna Boccuzzo, Simone Mocellin
A number of studies have indicated that the mitotic rate may be a predictive factor for poor prognosis in melanoma patients. The aim of this study was to investigate whether the mitotic rate is associated with other prognostic clinical and anatomopathological characteristics. After adjusting for other anatomopathological characteristics, we then verified the prognostic value of the number of mitoses, determining in which population subgroup this variable may have greater prognostic significance on 3-year mortality...
2024: PloS One
https://read.qxmd.com/read/38624106/use-of-imaging-in-cutaneous-squamous-cell-carcinoma-to-detect-high-risk-tumor-features-nodal-metastasis-and-distant-metastasis-a-systematic-review
#22
JOURNAL ARTICLE
Karissa Libson, Connor Sheridan, David R Carr, Kathryn T Shahwan
BACKGROUND: Imaging has been shown to impact management and disease outcomes in cutaneous squamous cell carcinoma, but the literature on optimal modalities is lacking. OBJECTIVE: To perform a systematic review evaluating the performance of various imaging studies for the detection of perineural spread, bony invasion, nodal metastasis (NM), and distant metastasis in cutaneous squamous cell carcinoma. MATERIALS AND METHODS: Four databases were searched for relevant terms...
April 16, 2024: Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.]
https://read.qxmd.com/read/38624045/rna-m6a-modification-shaping-cutaneous-melanoma-tumor-microenvironment-and-predicting-immunotherapy-response
#23
JOURNAL ARTICLE
Yanhong Wu, Hongying He, Kairong Zheng, Zhenxin Qin, Naikun Cai, Shuguang Zuo, Xiao Zhu
Recent years have seen rising mortality rates linked to cutaneous melanoma (SKCM), despite advances in immunotherapy. Understanding RNA N6-methyladenosine (M6A) significance in SKCM is crucial for prognosis, tumor microenvironment (TME), immune cell presence, and immunotherapy efficacy. We analyzed 23 M6A regulators using SKCM samples from TCGA and GEO databases, identifying three M6A modification patterns linked to TME cell infiltration. Principal component analysis (PCA) yielded an M6A score for individual tumors, utilizing patient gene expression profiles and CNV data from TCGA...
April 16, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38624009/pet-ct-vs-brain-mri-for-the-detection-of-cerebral-metastases-of-melanoma-a-5-year-retrospective-study
#24
JOURNAL ARTICLE
Lisa Tutic-Sorrentino, Simone Cazzaniga, Laurence Feldmeyer, Michael Benzaquen
BACKGROUND: Melanoma patients present a high risk of developing extra cutaneous metastases. PET-CT is one of the preferred examinations for the staging of oncological patients. It is not the method of choice to detect brain metastases, but this technique has shown significant improvement and allows the detection of some of them, although it is unclear how it performs compared to the MRI, the current gold standard for diagnosing brain metastases. OBJECTIVE: To compare the accuracy of PET-CT and cerebral MRI to detect brain metastases in melanoma patients...
April 16, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38622261/cold-atmospheric-plasma-attenuates-skin-cancer-via-ros-induced-apoptosis
#25
JOURNAL ARTICLE
Changqing Liu, Jingjing Zha, Tao Sun, Ling Kong, Xinru Zhang, Dong Wang, Guohua Ni
BACKGROUND: Cold atmospheric plasma (CAP) has been widely used in biomedical research, especially in vitro cancer therapy. Cutaneous squamous cell carcinoma (CSCC) is a malignant tumor originating from epidermal keratinocytes. However, the mechanism of CAP therapy on CSCC remains unclear. METHODS AND RESULTS: The animal models of CSCC induced by 7,12-dimethylbenz(a) anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) were constructed. For the CAP treatment group, after each TPA application, CAP was administered for 3 min twice weekly after drying...
April 15, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38618248/antibody-platinum-iv-prodrugs-conjugates-for-targeted-treatment-of-cutaneous-squamous-cell-carcinoma
#26
JOURNAL ARTICLE
Xiangye Yin, Yingjie Zhuang, Haiqin Song, Yujian Xu, Fan Zhang, Jianxin Cui, Lei Zhao, Yingjie Yu, Qixu Zhang, Jun Ye, Youbai Chen, Yan Han
Antibody-drug conjugates (ADCs) are a new type of targeting antibodies that conjugate with highly toxic anticancer drugs via chemical linkers to exert high specificity and efficient killing of tumor cells, thereby attracting considerable attention in precise oncology therapy. Cetuximab (Cet) is a typical antibody that offers the benefits of good targeting and safety for individuals with advanced and inoperable cutaneous squamous cell carcinoma (cSCC); however, its anti-tumor activity is limited to a single use...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38616510/congenital-localized-cutaneous-langerhans-cell-histiocytosis-in-a-holstein-calf
#27
JOURNAL ARTICLE
Jørgen S Agerholm, Gary Mason, David Steffen
Distinct solitary dermal nodules, either covered by an alopecic, or sometimes ulcerated, epidermis, were noticed on the head of a stillborn Holstein calf. The head was submitted for autopsy, and the nodules were found to consist of homogeneous, diffuse pale-yellow, soft-tissue masses with distinct margins that elevated the epidermis above the adjacent skin. Histologically, the dermal nodules were well-delineated on the deep margin approaching the cutaneous muscle and consisted of perivascular neoplastic infiltrates of round cells that in some places coalesced into sheets that extended into the dermis and subcutis...
April 14, 2024: Journal of Veterinary Diagnostic Investigation
https://read.qxmd.com/read/38615305/exploring-a-specialized-programmed-cell-death-patterns-to-predict-the-prognosis-and-sensitivity-of-immunotherapy-in-cutaneous-melanoma-via-machine-learning
#28
JOURNAL ARTICLE
Leyang Xiao, Ruifeng He, Kaibo Hu, Gelin Song, Shengye Han, Jitao Lin, Yixuan Chen, Deju Zhang, Wuming Wang, Yating Peng, Jing Zhang, Peng Yu
The mortality and therapeutic failure in cutaneous melanoma (CM) are mainly caused by wide metastasis and chemotherapy resistance. Meanwhile, immunotherapy is considered a crucial therapy strategy for CM patients. However, the efficiency of currently available methods and biomarkers in predicting the response of immunotherapy and prognosis of CM is limited. Programmed cell death (PCD) plays a significant role in the occurrence, development, and therapy of various malignant tumors. In this research, we integrated fourteen types of PCD, multi-omics data from TCGA-SKCM and other cohorts in GEO, and clinical CM patients to develop our analysis...
April 14, 2024: Apoptosis: An International Journal on Programmed Cell Death
https://read.qxmd.com/read/38613415/sox-10-and-trp-1-expression-in-feline-ocular-and-nonocular-melanomas
#29
JOURNAL ARTICLE
Margherita Orlandi, Ilaria Porcellato, Monica Sforna, Adriana Lo Giudice, Giuseppe Giglia, Luca Mechelli, Chiara Brachelente
In felines, ocular and nonocular melanomas are uncommon tumors that represent a diagnostic challenge for pathologists, especially when amelanotic. To date, the immunohistochemical diagnostic panel in cats is based on specific melanocytic markers (Melan-A and PNL2) and a nonspecific but sensitive marker (S100). In human medicine, SOX-10 is reported to be a sensitive antibody for the detection of melanoma micrometastasis in the lymph node. TRP-1, an enzyme involved in melanogenesis, has recently been used in humans and dogs as a specific melanocyte marker...
April 13, 2024: Veterinary Pathology
https://read.qxmd.com/read/38612803/in-silico-transcriptomic-expression-of-msr1-in-solid-tumors-is-associated-with-responses-to-anti-pd1-and-anti-ctla4-therapies
#30
JOURNAL ARTICLE
Adrián Sanvicente, Cristina Díaz-Tejeiro, Cristina Nieto-Jiménez, Lucia Paniagua-Herranz, Igor López Cade, Győrffy Balázs, Víctor Moreno, Pedro Pérez-Segura, Emiliano Calvo, Alberto Ocaña
Immuno-oncology has gained momentum with the approval of antibodies with clinical activities in different indications. Unfortunately, for anti-PD (L)1 agents in monotherapy, only half of the treated population achieves a clinical response. For other agents, such as anti-CTLA4 antibodies, no biomarkers exist, and tolerability can limit administration. In this study, using publicly available genomic datasets, we evaluated the expression of the macrophage scavenger receptor-A (SR-A) (MSR1) and its association with a response to check-point inhibitors (CPI)...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611601/diagnostic-and-therapeutic-particularities-of-symptomatic-melanoma-brain-metastases-from-case-report-to-literature-review
#31
Adelaida Avino, Daniela-Elena Ion, Daniela-Elena Gheoca-Mutu, Abdalah Abu-Baker, Andrada-Elena Țigăran, Teodora Peligrad, Cristian-Sorin Hariga, Andra-Elena Balcangiu-Stroescu, Cristian-Radu Jecan, Adrian Tudor, Laura Răducu
The recent introduction of immunotherapy and targeted therapy has substantially enriched the therapeutic landscape of metastatic melanoma. However, cerebral metastases remain unrelenting entities with atypical metabolic and genetic profiles compared to extracranial metastases, requiring combined approaches with local ablative treatment to alleviate symptoms, prevent recurrence and restore patients' biological and psychological resources for fighting malignancy. This paper aims to provide the latest scientific evidence about the rationale and timing of treatment, emphasizing the complementary roles of surgery, radiotherapy, and systemic therapy in eradicating brain metastases, with a special focus on the distinct response of intracranial and extracranial disease, which are regarded as separate molecular entities...
March 25, 2024: Diagnostics
https://read.qxmd.com/read/38611115/immune-related-adverse-events-due-to-cancer-immunotherapy-immune-mechanisms-and-clinical-manifestations
#32
REVIEW
Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti, Antonello Veccia
The landscape of cancer treatment has undergone a significant transformation with the introduction of Immune Checkpoint Inhibitors (ICIs). Patients undergoing these treatments often report prolonged clinical and radiological responses, albeit with a potential risk of developing immune-related adverse events (irAEs). Here, we reviewed and discussed the mechanisms of action of ICIs and their pivotal role in regulating the immune system to enhance the anti-tumor immune response. We scrutinized the intricate pathogenic mechanisms responsible for irAEs, arising from the evasion of self-tolerance checkpoints due to drug-induced immune modulation...
April 8, 2024: Cancers
https://read.qxmd.com/read/38611072/dermoscopy-as-a-tool-for-identifying-potentially-metastatic-thin-melanoma-a-clinical-dermoscopic-and-histopathological-case-control-study
#33
JOURNAL ARTICLE
Vincenzo De Giorgi, Flavia Silvestri, Giovanni Cecchi, Federico Venturi, Biancamaria Zuccaro, Gabriella Perillo, Federica Cosso, Vincenza Maio, Sara Simi, Pietro Antonini, Serena Pillozzi, Lorenzo Antonuzzo, Daniela Massi, Laura Doni
Despite being early-stage tumors, thin cutaneous melanomas contribute significantly to mortality and have a rising incidence. A retrospective case-control study was performed to identify clinical-dermoscopic and histopathological variables linked to local and distant metastases in melanomas ≤0.8 mm. Data from 1 January 2000 to 22 June 2022 were analyzed from two Italian skin cancer referral centers. Sixteen patients with ≤0.8 mm melanomas developing metastases were studied compared to controls without metastases over 5 years...
April 1, 2024: Cancers
https://read.qxmd.com/read/38611025/targeted-dna-sequencing-of-cutaneous-melanoma-identifies-prognostic-and-predictive-alterations
#34
JOURNAL ARTICLE
Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil, Katy K Tsai, Michael Tetzlaff, Adil Daud, Harish N Vasudevan
BACKGROUND: Cutaneous melanoma (CM) can be molecularly classified into four groups: BRAF mutant, NRAS mutant, NF1 mutant and triple wild-type (TWT) tumors lacking any of these three alterations. In the era of immune checkpoint inhibition (ICI) and targeted molecular therapy, the clinical significance of these groups remains unclear. Here, we integrate targeted DNA sequencing with comprehensive clinical follow-up in CM patients. METHODS: This was a retrospective cohort study that assessed clinical and molecular features from patients with localized or metastatic CM who underwent targeted next-generation sequencing as part of routine clinical care...
March 29, 2024: Cancers
https://read.qxmd.com/read/38608126/primary-cutaneous-adenoid-cystic-carcinoma-in-a-rare-location-with-an-immune-response-to-a-bnt162b2-vaccine-a-case-report
#35
JOURNAL ARTICLE
Abdurrahman Yilmaz, Barlas Goker, Mustafa Gokhan Gedikoglu, Mehmet Ayvaz, Ahmet Mazhar Tokgozoglu
CASE: In this report, a rare case of primary cutaneous adenoid cystic carcinoma (PCACC) localized in the subcutaneous tissue of the scapular region that grew after BNT162b2 corona virus disease of 2019 (COVID-19) vaccination is presented and may be explained by CD4 and CD8 cell infiltration. The BNT162b2 mRNA vaccine has been associated with a multisystem inflammatory syndrome (MIS-V). A comparable immune reaction could potentially enhance tumor growth rate. CONCLUSION: Primary cutaneous adenoid cystic carcinomas are rare tumors with unique locations...
April 1, 2024: JBJS Case Connector
https://read.qxmd.com/read/38605816/ethanol-extract-of-ampelopsis-brevipedunculata-rhizomes-suppresses-ige-mediated-mast-cell-activation-and-anaphylaxis
#36
JOURNAL ARTICLE
Ji-Yeong Park, Min-Jong Kim, Young-Ae Choi, Seung Woong Lee, Soyoung Lee, Yong Hyun Jang, Sang-Hyun Kim
More than 20% of the world's population suffers from allergic diseases, including allergic asthma, rhinitis, and atopic dermatitis that severely reduce the patient's quality of life. The treatment of allergy has been developed, but there are still unmet needs. Ampelopsis brevipedunculata (Maxim.) Trautv. is a traditional medicinal herb with beneficial bioactivities, such as antioxidant, anti-hypertension, anti-viral, anti-mutagenic, and skin and liver (anti-hepatotoxic) protective actions. However, its anti-allergic effect has not been addressed...
2024: Advances in pharmacological and pharmaceutical sciences
https://read.qxmd.com/read/38605354/thoc7-as1-oct1-fstl1-axis-promotes-emt-and-serves-as-a-therapeutic-target-in-cutaneous-squamous-cell-carcinoma
#37
JOURNAL ARTICLE
Site Yu, Xu Cui, Situo Zhou, Yun Li, Wenjie Feng, Xiangjun Zhang, Yuhui Zhong, Pihong Zhang
BACKGROUND: THOC7-AS1 and FSTL1 expression are frequently upregulated in cutaneous squamous cell carcinoma (cSCC). However, their molecular biological mechanisms remain elusive and their potential as therapeutic targets needs urgent exploration. METHODS: Human tissue samples were used to evaluate clinical parameters. In vitro and in vivo experiments assessed biological functions. Quantitative PCR, western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, RNA fluorescence in situ hybridization, RNA pull-down, RNA immunoprecipitation, silver staining, chromatin immunoprecipitation, dual luciferase reporter assays etc...
April 11, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38604100/metastatic-merkel-cell-carcinoma-to-the-thyroid-gland-case-report-and-review-of-the-literature
#38
REVIEW
Salmaan Sayeed, Danielle Kapustin, Samuel J Rubin, Jun Fan, Christina Wiedmer, Daniel Chung, Azita Khorsandi, Margaret Brandwein-Weber, Philip Friedlander, Richard Bakst, Ricardo J Ramirez, Mark L Urken
BACKGROUND: Merkel cell carcinoma (MCC) is an aggressive and rare neuroendocrine tumor, accounting for less than 1% of skin cancers. Metastasis primarily manifests in the cervical lymph nodes but rarely affect the thyroid. METHODS: We report a case of primary head and neck cutaneous MCC with metastasis to the thyroid gland. A review of the literature of MCC with thyroid metastasis was conducted. RESULTS: We identified five cases of MCC with thyroid metastasis...
April 4, 2024: American Journal of Otolaryngology
https://read.qxmd.com/read/38603804/lymphovascular-invasion-in-cutaneous-squamous-cell-carcinoma
#39
JOURNAL ARTICLE
Michael P Ryan, Frank T Winsett, Andrew M Armenta, Brandon P Goodwin, Richard F Wagner
BACKGROUND: Although there is a large body of literature regarding risk stratification and outcomes for perineural invasion (PNI) in cutaneous squamous cell carcinoma (cSCC), there is a relative paucity of studies exploring the role of lymphovascular invasion (LVI) in cSCC and a lack of clear evidence-based guidelines for how to manage patients with these tumors. OBJECTIVE: This article is intended to review the available literature regarding LVI in cSCC and formulate evidence-based recommendations for clinical management...
April 10, 2024: Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.]
https://read.qxmd.com/read/38603731/raman-difference-spectroscopy-and-u-net-convolutional-neural-network-for-molecular-analysis-of-cutaneous-neurofibroma
#40
JOURNAL ARTICLE
Levi Matthies, Hendrik Amir-Kabirian, Medhanie T Gebrekidan, Andreas S Braeuer, Ulrike S Speth, Ralf Smeets, Christian Hagel, Martin Gosau, Christian Knipfer, Reinhard E Friedrich
In Neurofibromatosis type 1 (NF1), peripheral nerve sheaths tumors are common, with cutaneous neurofibromas resulting in significant aesthetic, painful and functional problems requiring surgical removal. To date, determination of adequate surgical resection margins-complete tumor removal while attempting to preserve viable tissue-remains largely subjective. Thus, residual tumor extension beyond surgical margins or recurrence of the disease may frequently be observed. Here, we introduce Shifted-Excitation Raman Spectroscopy in combination with deep neural networks for the future perspective of objective, real-time diagnosis, and guided surgical ablation...
2024: PloS One
keyword
keyword
34816
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.